Anavex Life Sciences Corp.

Contributing Author

Recent Articles by Anavex Life Sciences Corp.

Sep-09	Anavex Life Sciences Announces Oral Blarcamesine Cognitive Resilience Results Approximating Normal Aging in New Precision Medicine Clinical Data from Phase IIb/III Alzheimer's Disease Trial AVXL GlobeNewswire
Sep-02	Anavex Life Sciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference 2025 AVXL GlobeNewswire
Aug-26	Anavex Life Sciences Reports New Publication in Medical Journal Highlighting the Established Precise Autophagy Mechanism with Blarcamesine AVXL GlobeNewswire
Aug-20	Anavex Life Sciences Announces New Publication in Medical Journal: Blarcamesine Prevented Cognitive Impairment in Animal Model of Alzheimer's Disease AVXL GlobeNewswire
Aug-12	Anavex Life Sciences Reports Fiscal 2025 Third Quarter Financial Results and Provides Business Update AVXL GlobeNewswire
Aug-05	Anavex Life Sciences to Announce Fiscal 2025 Third Quarter Financial Results on Tuesday, August 12, 2025 AVXL GlobeNewswire
Jul-31	Anavex Life Sciences Announces Positive Precision Medicine Results from up to 4-Years of Oral Blarcamesine Treatment in Phase IIb/III Open-Label Extension Trial in Early Alzheimer's Disease AVXL GlobeNewswire
May-14	Anavex Life Sciences to Participate at Upcoming Healthcare Conferences AVXL GlobeNewswire
May-13	Anavex Life Sciences Reports Fiscal 2025 Second Quarter Financial Results and Provides Business Update AVXL GlobeNewswire
May-06	Anavex Life Sciences to Announce Fiscal 2025 Second Quarter Financial Results on Tuesday, May 13, 2025 AVXL GlobeNewswire